These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11780428)

  • 1. Implantation of dual chamber pacemaker defibrillator and placement of endocardial leads via the axillary vein.
    Yang J; Powell A; Davis M
    Chin Med J (Engl); 2001 Jun; 114(6):568-70. PubMed ID: 11780428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
    Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
    G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
    Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
    Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to ablate and pace:AV junction ablation and pacemaker implantation performed concurrently from the same venous access site.
    Issa ZF
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1116-20. PubMed ID: 17725755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device management of arrhythmias after Fontan conversion.
    Tsao S; Deal BJ; Backer CL; Ward K; Franklin WH; Mavroudis C
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):937-40. PubMed ID: 19660377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival.
    Bhatia A; Cooley R; Berger M; Blanck Z; Dhala A; Sra J; Axtell-Mcbride K; Vandervort C; Akhtar M
    Curr Probl Cardiol; 2004 Jun; 29(6):303-56. PubMed ID: 15159713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.
    López Gil M; Arribas F; Cosío FG
    Europace; 2000 Oct; 2(4):327-32. PubMed ID: 11194600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of cardiac pacing in adults with congenital heart disease.
    Walker F; Siu SC; Woods S; Cameron DA; Webb GD; Harris L
    J Am Coll Cardiol; 2004 May; 43(10):1894-901. PubMed ID: 15145118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to transvenous dual-chamber pacing lead placement and cardiac defibrillator implantation after tricuspid valve replacement.
    Lopez JA; Lufschanowski R
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):873-5. PubMed ID: 18179526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach.
    Mathur G; Stables RH; Heaven D; Ingram A; Sutton R
    Europace; 2001 Jan; 3(1):56-9. PubMed ID: 11271953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.